AI assistant
Sending…
RESMED INC — Director's Dealing 2012
Feb 3, 2012
30071_dirs_2012-02-03_f4fb8aea-4e55-44cf-bf83-3b8b574f6b87.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-02-01
Reporting Person: Farrell Michael J. (President - Americas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-02-01 | ResMed Common Stock | M | 63 | $15.52 | Acquired | 53399.665 | Direct |
| 2012-02-01 | ResMed Common Stock | S | 63 | $29.52 | Disposed | 53336.665 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-02-01 | ResMed Common Stock Options | $15.520 | M | 63 | Disposed | 2015-11-20 | ResMed Common Stock (63) | Direct |
Footnotes
F1: Represents date options first became exercisable. Options vest 1/4 annually on the anniversary of the grant.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29